2011The FASEB JournalRequires access

Akt‐ and PKA‐mediated endothelial nitric oxide synthase activation triggers early ischemic preconditioning in isolated rat hearts

Changjun Yang, M.A. Hassan Talukder, Chun‐An Chen, Jay L. Zweíer

Open publisher page 1 citations

Abstract

Ischemic preconditioning (IPC) is a powerful cardioprotective phenomenon, however, the role of endothelial nitric oxide synthase (eNOS) and mechanisms of its activation are unclear in early IPC. While eNOS is an important downstream target of Akt and/or protein kinase A (PKA), questions remain regarding the role of Akt or PKA in eNOS activation and cardioprotection. Hearts were subjected to 30 min global ischemia and 120 min reperfusion (I/R) with or without IPC cycles (3 cycles of 5 min I and 5 min R). To address signaling proteins in the trigger phase and early R, myocardial tissues were collected following IPC cycles or inhibitors (PI3K inhibitor, LY294002/LY; PKA inhibitor, H89) plus IPC cycles or IPC cycles plus 30 min global I and 15 min R and Western blot analysis was performed. IPC significantly improved postischemic LVDP and reduced myocardial infarction compared to I/R group, and IPC effects were abrogated by L-NAME. I/R caused significant loss of total myocardial eNOS, and this loss was prevented by IPC. Phosphorylation of eNOS, Akt, and PKA was significantly increased following IPC. Pretreatment with LY or H89 either abolished or decreased phosphorylation of Akt or PKA, respectively. Importantly, LY or H89 abolished IPC-induced increase in eNOS activation and abrogated the cardioprotective effect of IPC. Thus, Akt- and PKA-mediated eNOS activation is critical for early IPC-induced cardioprotection.

About this research paper

What this paper is about

Ischemic preconditioning (IPC) is a powerful cardioprotective phenomenon, however, the role of endothelial nitric oxide synthase (eNOS) and mechanisms of its activation are unclear in early IPC. While eNOS is an important downstream target of Akt and/or protein kinase A (PKA), questions remain regarding the role of Akt or PKA in eNOS activation and cardioprotection. Hearts were subjected to 30 min global ischemia and 120 min reperfusion (I/R) with or without IPC cycles (3 cycles of 5 min I and 5 min R). To address signaling proteins in the trigger phase and early R, myocardial tissues were collected following IPC cycles or inhibitors (PI3K inhibitor, LY294002/LY; PKA inhibitor, H89) plus IPC cycles or IPC cycles plus 30 min global I and 15 min R and Western blot analysis was performed. IPC significantly improved postischemic LVDP and reduced myocardial infarction compared to I/R group, and IPC effects were abrogated by L-NAME. I/R caused significant loss of total myocardial eNOS, and this loss was prevented by IPC. Phosphorylation of eNOS, Akt, and PKA was significantly increased following IPC. Pretreatment with LY or H89 either abolished or decreased phosphorylation of Akt or PKA, respectively. Importantly, LY or H89 abolished IPC-induced increase in eNOS activation and abrogated the cardioprotective effect of IPC. Thus, Akt- and PKA-mediated eNOS activation is critical for early IPC-induced cardioprotection.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ischemic preconditioning (IPC) is a powerful cardioprotective phenomenon, however, the role of endothelial nitric oxide synthase (eNOS) and mechanisms of its activation are unclear in early IPC. While eNOS is an important downstream target of Akt and/or protein kinase A (PKA), questions remain regarding the role of Akt or PKA in eNOS activation and cardioprotection. Hearts were subjected to 30 min global ischemia and 120 min reperfusion (I/R) with or without IPC cycles (3 cycles of 5 min I and 5 min R). To address signaling proteins in the trigger phase and early R, myocardial tissues were collected following IPC cycles or inhibitors (PI3K inhibitor, LY294002/LY; PKA inhibitor, H89) plus IPC cycles or IPC cycles plus 30 min global I and 15 min R and Western blot analysis was performed. IPC significantly improved postischemic LVDP and reduced myocardial infarction compared to I/R group, and IPC effects were abrogated by L-NAME. I/R caused significant loss of total myocardial eNOS, and this loss was prevented by IPC. Phosphorylation of eNOS, Akt, and PKA was significantly increased following IPC. Pretreatment with LY or H89 either abolished or decreased phosphorylation of Akt or PKA, respectively. Importantly, LY or H89 abolished IPC-induced increase in eNOS activation and abrogated the cardioprotective effect of IPC. Thus, Akt- and PKA-mediated eNOS activation is critical for early IPC-induced cardioprotection.

Key concepts: Enos, Cardioprotection, Protein kinase B, Phosphorylation, Ischemic preconditioning, Nitric oxide, PI3K/AKT/mTOR pathway, LY294002

Related papers

Back to paper searchBrowse research topicsOriginal source
Akt‐ and PKA‐mediated endothelial nitric oxide synthase activation triggers early ischemic preconditioning in isolated rat hearts — Research Paper | ScholarLens